Crossmark

Targeting MARCO in combination with anti-CTLA-4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming

Crossref DOI link: https://doi.org/10.1136/jitc-2024-011030

Published Online: 2025-03-13

Published Print: 2025-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Takahashi, Hidenori https://orcid.org/0000-0001-7872-1519
Perez-Villarroel, Patricio https://orcid.org/0000-0003-1997-5994
Falahat, Rana https://orcid.org/0000-0001-7489-3807
Mulé, James J https://orcid.org/0000-0001-7354-0516
Funding

Funding for this research was provided by:

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (N/A)

Chris Sullivan Fund (N/A)

CJG Fund (N/A)

NIH (1R01 CA148995)

NIH (1R01 CA184845)

NIH (P30 CA076292)

NIH (P50 CA168536)

V Foundation (N/A)
License Information

License valid from 2025-03-11